Article

Perimeter's diagnostic capabilities allow for early detection of CNV

The Foresee PHP, a second-generation Preferential Hyperacuity Perimeter is available for improved detection and early diagnosis of the most aggressive and sight-threatening form of age-related macular degeneration (AMD). Developed by Notal Vision and distributed exclusively in the United States by MSS, the device represents a technologic leap for monitoring AMD and is a clinically validated diagnostic device for improved early detection of choroidal neovascularization (CNV).

The Foresee PHP, a second-generation Preferential Hyperacuity Perimeter, is available for improved detection and early diagnosis of the most aggressive and sight-threatening form of age-related macular degeneration (AMD). Developed by Notal Vision and distributed exclusively in the United States by MSS, the device represents a technologic leap for monitoring AMD and is a clinically validated diagnostic device for improved early detection of choroidal neovascularization (CNV).

The device is the follow-up to the Preview PHP and allows eye-care professionals to track any changes to a patient's visual field resulting from the advancement of AMD. The updated device is completely automated, allowing for patient self-operation, while still exhibiting high sensitivity and specificity. The Foresee PHP also has a larger normative database, provides faster testing and test analysis, and generates advanced reports that feature a map of the patient's visual field indicating the relative location of abnormalities in the macular area.

The Foresee PHP maps defects within a patient's visual field by analyzing responses to "dot deviation signals" flashing on a computer screen. The patient uses a stylus pen to touch the screen to identify the most prominent distortion in the line. The response patterns are recorded, analyzed and compared with the normative database, producing a report revealing the relative location of the defects in the macular area.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.